Zeng found that high ARD1 expression correlated positively with the survival rate of breast cancer patients and negatively with lymph node metastasis, indicating that ARD1 may enhance prognosis by inhibiting cancer cell migration and invasion. The gene discussed is NAA10; the disease is breast carcinoma.